Glial inflammatory response

The glial inflammatory response is a complex biological process involving the activation of microglia and astrocytes within the central nervous system in response to pathological stimuli (Glass et al., 2010, Cell). While acute activation serves a protective role by clearing cellular debris and pathogens, chronic glial inflammation is a primary driver of neurodegeneration in diseases such as Alzheimer's and Parkinson's (Colonna & Butovsky, 2017, Immunity). Activated glia release a variety of pro-inflammatory mediators, including cytokines (e.g., TNF-alpha, IL-1 beta), chemokines, and reactive oxygen species, which can lead to collateral neuronal damage (Liddelow et al., 2017, Nature). Pharmacological intervention typically focuses on modulating these cellular pathways to suppress neurotoxic signaling while preserving or enhancing neuroprotective functions. Because it encompasses a broad array of cellular activities and signaling cascades, it is classified as a physiological process rather than a single molecular target (Leng & Edison, 2021, Nature Reviews Neurology).

Other names

NeuroinflammationGlial activationMicroglial activationAstrogliosisReactive gliosisNeuroinflammatory response

Modulation of glial phenotypes from pro-inflammatory (M1/A1) to anti-inflammatory (M2/A2) states, inhibition of pro-inflammatory cytokine release, and suppression of reactive oxygen species production (Glass et al., 2010, Cell).